Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation Trial-Reference-Cited by-同舟云学术

Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation Trial

Published:2017-05 Issue: Volume:177 Page:150-158
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Constable Ian J.,Lai Chooi-May,Magno Aaron L.,French Martyn A.,Barone Samuel B.,Schwartz Steven D.,Blumenkranz Mark S.,Degli-Esposti Mariapia A.,Rakoczy Elizabeth P.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference37 articles.

1. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis;Wong;Ophthalmology,2008

2. Prevalence of age-related macular degeneration in the United States;Friedman;Arch Ophthalmol,2004

3. Age-related macular degeneration (AMD): pathogenesis and therapy;Nowak;Pharmacol Rep,2006

4. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results;Kaiser;Am J Ophthalmol,2007

5. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1;Regillo;Am J Ophthalmol,2008

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble FLT-1 in angiogenesis: pathophysiological roles and therapeutic implications;Angiogenesis;2024-08-29

2. Gene Therapies in Clinical Development to Treat Retinal Disorders;Molecular Diagnosis & Therapy;2024-07-02

3. Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice;Experimental Eye Research;2024-07

4. Adeno-associated virus as a delivery vector for gene therapy of human diseases;Signal Transduction and Targeted Therapy;2024-04-03

5. A multinational survey of potential participant perspectives on ocular gene therapy;Gene Therapy;2024-04-02